Instrumento Inactivo

Otros idiomas Occlutech Holding AG

Acciones

Occlutech Holding AG Continues its Progress in US FDA Study OCCLUFLEX – Enrolls First Patient in Europe	31/01/23
Occlutech Holding AG Appoints Jozef Bartunek as New Chief Medical Officer	01/11/22
Occlutech Holding AG Appoints Jose De La Cortina as Chief Commercial Officer	06/09/22
Occlutech Holding AG announced that it has received SEK 450 million in funding from AP Fonden 4, Carnegie Investment Bank AB	21/12/21
Occlutech Holding AG has withdrawn its IPO in the amount of SEK 963.8035 million.	28/09/21
Occlutech Holding AG has filed an IPO in the amount of SEK 963.8035 million.	08/09/21
Occlutech Holding AG announced that it has received funding from COI Partners	31/12/12

No hay resultados para esta búsqueda